Cape Investment Advisory, Inc. Charles River Laboratories International, Inc. Transaction History
Cape Investment Advisory, Inc.
- $247 Billion
- Q3 2024
A detailed history of Cape Investment Advisory, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 138 shares of CRL stock, worth $26,127. This represents 0.01% of its overall portfolio holdings.
Number of Shares
138
Previous 142
2.82%
Holding current value
$26,127
Previous $29.3 Million
7.34%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$963 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$708 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$403 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$367 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.63B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...